While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory ...

The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

The update covers devices used in procedures to implant the company’s Watchman heart device.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.

Boston Scientific improved B2B search experiences by integrating AI-enabled search from Coveo into their SAP Commerce Cloud stack.

Boston Scientific Corporation (NYSE:BSX) is one of the most profitable growth stocks to buy according to billionaires.

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...